Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Medicinal composition for treating cholelithiasis and its preparing method

A composition and technology for gallstone disease, applied in the field of preparation of the drug, can solve the problems of not very significant effect, low cure rate, and long course of treatment, and achieve the effects of enhancing the body's immunity, increasing the therapeutic effect, and preventing recurrence

Inactive Publication Date: 2006-11-29
梅喜
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0005] 2. Oral stone-dissolving medicine, chenodeoxycholic acid, ursodeoxycholic acid, and ursodeoxycholic acid have a long course of treatment and a small scope of application. They are only suitable for cholesterol stones smaller than 1.5cm. The cure rate is low, and the cure rate after taking the medicine for two years 30-60%, the recurrence rate within two years is 50%, and the monoterpene mixture generally only has a 6-7% stone dissolution rate;
[0007] 4. Electroacupuncture for stone removal and stone removal instrument have only a certain curative effect;
[0008] 5. Surgical perfusion litholysis: the equipment is complicated, the operation requirements are high, the price is expensive, and it cannot be popularized;
[0009] 6. In vitro lithotripsy is suitable for some patients, about 20%. Although there are some Chinese patent medicines for treating cholelithiasis, the effect is not very significant, such as Lidan Paishi tablets, Jieshitong, etc.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0062] Weigh raw materials according to the following ratio

[0063] Polygonum cuspidatum 90kg Verbena 90kg Compound bile powder 2kg

[0064] Bupleurum 70kg Gynostemma 10kg Turmeric 6kg

[0065] Gantaile 1kg, erythromycin 2kg, proglutamine 4kg,

[0066] The compound gallbladder powder is composed of 60% pig gallbladder powder, 30% sheep gallbladder powder and 10% rabbit gallbladder powder.

[0067] The production method is as follows:

[0068] First dry and pulverize the turmeric to 120 mesh fine powder, make the knotweed into a coarse powder, reflux with 95% ethanol for 3 times, filter, recover the ethanol from the filtrate under reduced pressure, collect the paste, dry and pulverize; use the verbena coarse powder 95% reflux extraction 4 times, 1 hour each time, the alcohol extract was concentrated under reduced pressure and saturated lead acetate aqueous solution was added until the precipitation was complete. Add saturated sulfuric acid solution to the filtrate to remove ...

Embodiment 2

[0070] Weigh raw materials according to the following ratio

[0071] Polygonum cuspidatum 9kg Verbena 40kg Compound bile powder 2kg

[0072] Bupleurum 9kg Gynostemma 7kg Turmeric 6kg

[0073] Gantaile 1kg, erythromycin 1kg, proglumide 4kg, the compound gall powder is composed of 60% pig gall powder, 30% sheep gall powder and 10% rabbit gall powder, and its preparation method is the same as in Example 1.

Embodiment 3

[0075] Weigh raw materials according to the following ratio

[0076] Polygonum cuspidatum 120kg Verbena 120kg Compound bile powder 25kg

[0077] Bupleurum 120kg Gynostemma 30kg Turmeric 90kg

[0078] Gantaile 5kg, erythromycin 5kg, proglumide 10kg, the composite gallbladder powder is made up of 60% pig gallbladder powder, 30% sheep gallbladder powder and 10% rabbit gallbladder powder, and its preparation method is the same as in Example 1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The medicinal composition for treating cholelithiasis is prepared with giant knotwood, European verbena, compound bile powder, bupleurum root, gynostemma pentaphylla, curcuma root, glucurolactone, erythromycin and proglumide as material, and through stoving, crushing, solvent extraction, mixing in certain proportion, sterilizing and other steps. It is prepared into common preparation forms, and the present invention has unique recipe, unique preparation process and obvious curative effect.

Description

technical field [0001] The invention relates to a medicine for treating gallstone disease, specifically a Chinese patent medicine mainly prepared from plant Chinese herbal medicine, which combines traditional Chinese and Western medicine, and also relates to a preparation method of the medicine. Background technique [0002] Cholelithiasis is a common and frequently-occurring disease that seriously endangers human health. The incidence rate is between 1-10%, and there is a trend of increasing year by year. 1.2% cholelithiasis can evolve into cancer. The mortality rate from complications of gallstone disease in patients over 60 years old is as high as 15.3%. [0003] At present, the treatment of this disease at home and abroad has encountered the following thorny problems. [0004] 1. The incidence of residual stones in surgical treatment is 10-15%, the incidence of complications is 15%, and the mortality rate of surgery is 0.5-3%. Patients generally require non-surgical tre...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K36/9066A61K36/85A61K36/704A61K36/424A61K36/233A61K35/413A61K31/7048A61K31/195A61K9/00A61P1/16
Inventor 梅喜
Owner 梅喜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products